SURGERY PARTNERS INC (SGRY) Stock Earnings & Estimates
NASDAQ:SGRY - US86881A1007 - Common Stock
22.58 USD
-0.11 (-0.48%)
22.58 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.539B 14.12% | 2.743B 8.03% | 3.114B 13.52% | 3.423B 9.91% | 3.755B 9.70% | 4.134B 10.09% | 4.62B 11.76% | 5.092B 10.22% | |
| EBITDA YoY % growth | 489.3M 21.44% | 533M 8.93% | 626.9M 17.62% | 571.55M -8.83% | 639.75M 11.93% | 721.81M 12.83% | N/A | N/A | |
| EBIT YoY % growth | 374.5M 23.15% | 414.9M 10.79% | 474.3M 14.32% | 437.27M -7.81% | 522.93M 19.59% | 541.4M 3.53% | N/A | N/A | |
| Operating Margin | 14.75% | 15.12% | 15.23% | 12.77% | 13.93% | 13.10% | N/A | N/A | |
| EPS YoY % growth | 0.13 208.33% | 0.99 661.54% | 0.94 -5.05% | 0.86 -8.14% | 1.11 28.34% | 1.33 20.32% | 2.02 51.47% | 2.50 23.74% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.18 -7.57% | 0.49 11.18% | 0.04 4.19% | 0.24 40.32% | 0.28 57.30% | 0.59 20.07% | 0.07 78.66% | 0.29 20.02% | 0.34 24.31% | 0.65 10.97% |
| Revenue Q2Q % growth | 838.13M 8.79% | 947.09M 9.57% | 871M 12.24% | 931.95M 12.80% | 926.37M 10.53% | 1.044B 10.23% | 959.1M 10.11% | 1.013B 8.70% | 1.027B 10.86% | 1.147B 9.87% |
| EBITDA Q2Q % growth | 140.63M -35.79% | 189.16M -41.90% | 117.17M -6.93% | 149.81M -24.30% | 159.65M 13.52% | 211.15M 11.63% | 132.5M 13.08% | 170.35M 13.71% | 180.35M 12.97% | 235.4M 11.48% |
| EBIT Q2Q % growth | 112.01M 11.67% | 172.35M -0.38% | 86.917M -2.99% | 123.3M 1.65% | 126.68M 13.10% | 183.53M 6.49% | 87.706M 0.91% | 123.46M 0.13% | 130.77M 3.23% | 185.37M 1.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.17 -19.05% | 0.14 | 0.03 | 24.15% |
| Q1 2025 Q2Q % growth | 0.04 -60.00% | 0.05 | -0.01 | -24.34% |
| Q4 2024 Q2Q % growth | 0.44 | 0.38 | 0.06 | 14.96% |
| Q3 2024 Q2Q % growth | 0.19 | 0.26 | -0.07 | -26.04% |
| Q2 2024 Q2Q % growth | 0.21 -25.00% | 0.20 | 0.01 | 2.99% |
| Q1 2024 Q2Q % growth | 0.10 25.00% | 0.07 | 0.03 | 37.02% |
| Q4 2023 Q2Q % growth | 0.44 62.96% | 0.39 | 0.05 | 13.88% |
| Q3 2023 Q2Q % growth | 0.19 1,050.00% | 0.17 | 0.02 | 14.21% |
| Q2 2023 Q2Q % growth | 0.28 1,033.33% | 0.08 | 0.20 | 238.52% |
| Q1 2023 Q2Q % growth | 0.08 188.89% | 0.00 | 0.08 | 1,911.06% |
| Q4 2022 Q2Q % growth | 0.27 17.39% | 0.19 | 0.08 | 43.08% |
| Q3 2022 Q2Q % growth | -0.02 60.00% | 0.05 | -0.07 | -142.97% |
| Q2 2022 Q2Q % growth | -0.03 | -0.01 | -0.02 | -335.73% |
| Q1 2022 Q2Q % growth | -0.09 70.00% | -0.06 | -0.03 | -44.65% |
| Q4 2021 Q2Q % growth | 0.23 155.56% | 0.20 | 0.03 | 16.36% |
| Q3 2021 Q2Q % growth | -0.05 90.57% | -0.11 | 0.06 | 53.04% |
| Q2 2021 Q2Q % growth | 0.00 100.00% | -0.19 | 0.19 | 100.00% |
| Q1 2021 Q2Q % growth | -0.30 11.76% | -0.38 | 0.08 | 20.78% |
| Q4 2020 Q2Q % growth | 0.09 -10.00% | 0.02 | 0.07 | 445.67% |
| Q3 2020 Q2Q % growth | -0.53 -89.29% | -0.39 | -0.14 | -37.24% |
| Q2 2020 Q2Q % growth | -1.36 -368.97% | -0.71 | -0.65 | -92.77% |
| Q1 2020 Q2Q % growth | -0.34 19.05% | -0.49 | 0.15 | 30.90% |
| Q4 2019 Q2Q % growth | 0.10 | 0.13 | -0.03 | -20.94% |
| Q3 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -12.81% |
| Q2 2019 Q2Q % growth | -0.29 | -0.18 | -0.11 | -64.58% |
| Q1 2019 Q2Q % growth | -0.42 | -0.28 | -0.14 | -49.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 826.2M 8.41% | 833.31M | -7.11M | -0.85% |
| Q1 2025 Q2Q % growth | 776M 8.17% | 792.63M | -16.63M | -2.10% |
| Q4 2024 Q2Q % growth | 864.4M 17.54% | 844.66M | 19.74M | 2.34% |
| Q3 2024 Q2Q % growth | 770.4M 14.29% | 785.16M | -14.76M | -1.88% |
| Q2 2024 Q2Q % growth | 762.1M 14.16% | 750.28M | 11.82M | 1.58% |
| Q1 2024 Q2Q % growth | 717.4M 7.69% | 712.19M | 5.21M | 0.73% |
| Q4 2023 Q2Q % growth | 735.4M 4.00% | 756.34M | -20.94M | -2.77% |
| Q3 2023 Q2Q % growth | 674.1M 8.62% | 685.72M | -11.62M | -1.69% |
| Q2 2023 Q2Q % growth | 667.6M 8.48% | 681.74M | -14.14M | -2.07% |
| Q1 2023 Q2Q % growth | 666.2M 11.74% | 670.24M | -4.04M | -0.60% |
| Q4 2022 Q2Q % growth | 707.1M 15.88% | 702.47M | 4.63M | 0.66% |
| Q3 2022 Q2Q % growth | 620.6M 10.98% | 647.73M | -27.13M | -4.19% |
| Q2 2022 Q2Q % growth | 615.4M 13.27% | 631.36M | -15.96M | -2.53% |
| Q1 2022 Q2Q % growth | 596.2M 16.35% | 581.26M | 14.94M | 2.57% |
| Q4 2021 Q2Q % growth | 610.2M 11.29% | 634.18M | -23.98M | -3.78% |
| Q3 2021 Q2Q % growth | 559.2M 12.72% | 556.77M | 2.43M | 0.44% |
| Q2 2021 Q2Q % growth | 543.3M 45.00% | 549.07M | -5.77M | -1.05% |
| Q1 2021 Q2Q % growth | 512.4M 16.19% | 509.04M | 3.36M | 0.66% |
| Q4 2020 Q2Q % growth | 548.3M 6.01% | 557.53M | -9.23M | -1.66% |
| Q3 2020 Q2Q % growth | 496.1M 9.76% | 476.78M | 19.32M | 4.05% |
| Q2 2020 Q2Q % growth | 374.7M -15.87% | 348.92M | 25.78M | 7.39% |
| Q1 2020 Q2Q % growth | 441M 5.81% | 404.6M | 36.4M | 9.00% |
| Q4 2019 Q2Q % growth | 517.2M | 524.9M | -7.7M | -1.47% |
| Q3 2019 Q2Q % growth | 452M | 462.19M | -10.19M | -2.20% |
| Q2 2019 Q2Q % growth | 445.4M | 460.45M | -15.05M | -3.27% |
| Q1 2019 Q2Q % growth | 416.8M | 432.08M | -15.28M | -3.54% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -26.19% | -35.27% | -3.84% | -8.78% |
| Revenue | -1.52% | -3.42% | -0.58% | -0.73% |